Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

<p>This study aimed to investigate the effectiveness and safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis (RA) in the real world. All consecutive patients with RA from the KEIO-RA cohort who had received a JAKi from July 2013 to June 2023 were included. We assess...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Satoshi Takanashi (15221350) (author)
Weitere Verfasser: Masatoshi Kawai (2074750) (author), Mitsuhiro Akiyama (3412106) (author), Yasushi Kondo (371654) (author), Shuntaro Saito (4519816) (author), Masaru Takeshita (6197132) (author), Jun Kikuchi (266172) (author), Hironari Hanaoka (3910738) (author), Yuko Kaneko (839653) (author)
Veröffentlicht: 2025
Schlagworte:
Biochemistry
Medicine
Pharmacology
Biotechnology
Ecology
Immunology
Developmental Biology
Science Policy
Chemical Sciences not elsewhere classified
Rheumatoid arthritis
JAK inhibitors
difficult-to-treat rheumatoid arthritis
retention rates
effectiveness
safety
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge